Ernexa Therapeutics announced a virtual investor event on October 15, featuring its CEO and scientific leaders discussing the advancement of their lead cell therapy candidate, ERNA-101, aimed at treating advanced cancers like ovarian cancer. The event will include a corporate overview, scientific insights into their induced pluripotent stem cell technology, and a Q&A session. This presentation highlights Ernexa's progress toward clinical development of off-the-shelf cell therapies designed to activate the immune system against cancer. A replay will be available for 90 days after the live webcast.
Ernexa Therapeutics news provides context for readers interested in health sector stocks. As of Oct 13, 2026 03:02 WIB, 66 of 128 priced US health stocks rose while 61 fell on Pluang. Notable movers include BRKR at USD 56.03 with a -4.78% change, MMED at USD 18.85 down -4.36%, and DFTX at USD 35.29 down -4.36% with 100% buy order activity and a typical hold time of 2 days on Pluang.
Pepeto, a new Ethereum-based cryptocurrency, has launched its page on CoinMarketCap, indicating a Binance listing is near. The project features a working bridge across Ethereum, BNB Chain, and Solana, with zero-cost token transfers and AI contract ch...
Crédit Agricole has signed an agreement to acquire 100% of IKB Deutsche Industriebank, a key financier for Germany's Mittelstand companies. This acquisition strengthens Crédit Agricole's expansion in Germany, Europe's largest economy, aligning with i...
Crédit Agricole has signed an agreement to acquire 100% of IKB Deutsche Industriebank, a key financial partner for Germany's Mittelstand companies. This acquisition aligns with Crédit Agricole's ACT 2028 strategic plan to expand in Europe, particular...
The complicated urinary tract infections (cUTI) market is projected to expand steadily through 2036, driven by increasing antimicrobial resistance, higher rates of recurrent and hospital-acquired infections, and more patients with underlying conditio...
Integrated Power Services (IPS) has acquired Bold Renewables, the exclusive OEM provider of parts and field services for Advanced Energy solar inverters. This acquisition strengthens IPS's renewable energy platform by adding specialized inverter life...
